Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2025-12-05$0.96/sh+10,000$9,600→ 766,460 total
Footnotes (1)
- [F1]Reflects open market purchases of the Issuer's securities.